Joseph G. Kern

Joseph G. Kern

Auto-generated profile, based on publicly available information

Joseph G. Kern

Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, United States of America

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JKJoseph G. Kern
Joseph G. Kern
ATAndrew Tilston-Lunel
Andrew Tilston-Lunel
AFAnthony Federico
Anthony Federico
BNBoting Ning
Boting Ning
AMAmy Mueller
Amy Mueller
XVXaralabos Varelas
Xaralabos Varelas
Basal-like breast cancers, an aggressive breast cancer subtype that has poor treatment options, are thought to arise from luminal mammary epithelial cells that undergo basal plasticity through poorly understood mechanisms. Using genetic mouse models and ex vivo primary organoid cultures, we show that conditional co-deletion of the LATS1 and LATS2 kinases, key effectors of Hippo pathway signaling, in mature mammary luminal epithelial cells promotes the development of Krt14 and Sox9-expressing basal-like carcinomas that metastasize over time. Genetic co-deletion experiments revealed that phenotypes resulting from the loss of LATS1/2 activity are dependent on the transcriptional regulators YAP/TAZ. Gene expression analyses of LATS1/2-deleted mammary epithelial cells notably revealed a transcriptional program that associates with human basal-like breast cancers. Our study demonstrates in vivo roles for the LATS1/2 kinases in mammary epithelial homeostasis and luminal-basal fate control and implicates signaling networks induced upon the loss of LATS1/2 activity in the development of basal-like breast cancer.

18 May 2023 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
AFAnthony Federico
Anthony Federico
JKJoseph Kern
Joseph Kern
XVXaralabos Varelas
Xaralabos Varelas
SMStefano Monti
Stefano Monti
Inference of biological network structures is often performed on high-dimensional data, yet is hindered by the limited sample size of high throughput “omics” data typically available. To overcome this challenge, often referred to as the “small n, large p problem,” we exploit known organizing principles of biological networks that are sparse, modular, and likely share a large portion of their underlying architecture. We present SHINE—Structure Learning for Hierarchical Networks—a framework for defining data-driven structural constraints and incorporating a shared learning paradigm for efficiently learning multiple Markov networks from high-dimensional data at large p/n ratios not previously feasible. We evaluated SHINE on Pan-Cancer data comprising 23 tumor types, and found that learned tumor-specific networks exhibit expected graph properties of real biological networks, recapture previously validated interactions, and recapitulate findings in literature. Application of SHINE to the analysis of subtype-specific breast cancer networks identified key genes and biological processes for tumor maintenance and survival as well as potential therapeutic targets for modulating known breast cancer disease genes.